Properties
What is it?
Name - Mominex Nasal Spray 50mcg/1dose 140doses Vial #1 IndicationsSeasonal and perennial allergic rhinitis treatment in adults, adolescents, and children 2 years of age and older.Prophylaxis of seasonal allergic rhinitis in adults and adolescents 12 years of age and older (recommended to be carried out 2-4 weeks before the expected start of the pollen season).Treatment of nasal polyposis accompanied by nasal obstruction and loss of sense of smell in adults 18 years of age and older.Method of use and dosageWhen using the spray for the first time or if the spray has not been used for 14 days or more, to adjust the pulverizer, it is necessary to press it about 10 times until normal suspension is dispensed. Each press on the dosing device dispenses approximately 100mcg of suspension containing 50mcg of mometasone furoate equivalent to mometasone furoate monohydrate. If the spray has not been used for 14 days or more, then before use, it is necessary to press the dispenser 2 times to dispense the suspension normally.Shake the vial before each useSeasonal or perennial allergic rhinitisAdults (including the elderly) and adolescents:The recommended dose is usually 2 inhalations (50mcg/1 inhalation) in each nostril once a day (total daily dose - 200mcg). After achieving the therapeutic effect, for maintenance therapy, the dose can be reduced to 1 inhalation in each nostril once a day (total daily dose 100mcg).If the symptoms of the disease cannot be reduced with the recommended therapeutic doses, the daily dose can be increased to 4 inhalations in each nostril once a day (total daily dose 400mcg). After reducing the symptoms of the disease, it is recommended to reduce the dose.Children 2-11 years of age:The usual recommended dose is 1 inhalation (50mcg/1 inhalation) in each nostril once a day (total daily dose - 100mcg).The clinically significant effect of nasal spray in patients with seasonal allergic rhinitis begins within 12 hours of the first use, but the full therapeutic effect may not be achieved within the first 48 hours. Therefore, to achieve full therapeutic effect, patients should continue to use the preparation regularly.The use of the preparation in children should be under adult supervision.Nasal polyposisAdults (including the elderly) and adolescents 18 years of age and older:The usual recommended starting dose is 2 inhalations (50mcg/1 inhalation) in each nostril once a day (total daily dose - 200mcg). If the symptoms of the disease cannot be reduced within 5-6 weeks of therapy, the daily dose can be increased to 2 inhalations in each nostril 2 times a day (total daily dose 400mcg). After reducing the symptoms of the disease, the dose should be reduced to the minimum that allows effective control of symptoms. If the symptoms of the disease cannot be reduced with the preparation used 2 times a day for 5-6 weeks, alternative forms of therapy should be considered.Method of useWhen using the nasal spray for the first time, it is necessary to shake the vial well and press the dosing device 10 times for normal suspension dispensing. If the spray has not been used for 14 days or more, then before use, it is necessary to press the dispenser 2 times to dispense the suspension normally.Shake the spray vial vigorously before each use. After using the prescribed amount of dose or 2 months after use, discard the vial